Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly launches insulin pen in selected markets:

This article was originally published in Clinica

Executive Summary

Eli Lilly is continuing the launch of its HumaPen, a reusable insulin injection device. The product is designed to work only with Lilly's range of insulin products in 3ml cartridges. The product was launched first in Canada, Australia and Japan. Last month, the UK and Holland were added to the list and the company is investigating further national launches in Europe. The company's spokesperson said there were no plans to apply for FDA approval as the US market tends to prefer prefilled pens.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT082200

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel